Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of chemotherapy-induced mitochondrial DNA changes and fatigue in metastatic testicular cancer
NL-OMON45432Active, not recruiting
- Sponsor
- Interne Oncologie
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bleomycin, etoposide and cisplatin in Germ Cell Testicular Cancer, sponsored by Interne Oncologie. Primary endpoint: Mitochondrial DNA change feasibility endpoint. Started Feb 2017; status: active, not recruiting.
02
Drugs
bleomycinetoposidecisplatin
03
Conditions
Germ Cell Testicular Cancer
Beyond the preview
Go deeper on NL-OMON45432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45432.